Doctor profile · Federal record
Dr. GEORGE DANIEL, MD
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · BOYNTON BEACH, FL
- NPI 1194799502
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 40 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2923 S FEDERAL HWY STE 100
BOYNTON BEACH, FL 334357745
(561) 752-0100
fax (561) 740-3001
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- June 27, 2024
- Year of graduation
- 1986 — 40 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Florida #ME87925
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1194799502. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
7,381
Distinct HCPCS
10
Medicare allowed
$977,341
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,263 | 630 | $132 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 771 | 304 | $83 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 735 | 609 | $15 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 395 | 296 | $8 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 375 | 361 | $200 | |
G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 341 | 50 | $38 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 300 | 298 | $69 | |
93298 |
Evaluation of cardiac rhythm monitor system, remote up to 30 days | 296 | 45 | $27 | |
J2785 |
Injection, regadenoson, 0.1 mg | 292 | 72 | $53 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 289 | 249 | $137 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 151. This provider delivers 49× the peer median.Open Payments
Industry payments received
All-time total
$2,058
Transactions
51
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 14 | $935.39 | |
| Novartis Pharmaceuticals Corporation | 7 | $142.84 | |
| ABIOMED | 1 | $111.11 | |
| Boston Scientific Corporation | 1 | $107.06 | |
| Merck Sharp & Dohme LLC | 3 | $78.55 | |
| Janssen Pharmaceuticals, Inc | 4 | $76.73 | |
| Lexicon Pharmaceuticals, Inc. | 2 | $62.49 | |
| Amgen Inc. | 3 | $61.36 | |
| Kestra Medical Technology Services, Inc. | 2 | $56.58 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $51.82 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $48.20 | |
| Medtronic, Inc. | 2 | $42.66 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37.78 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $37.36 | |
| Alnylam Pharmaceuticals Inc. | 2 | $34.52 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,808
Patients
1,048
Total drug cost
$630,158
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 487 | 187 | $9,275 |
| Atorvastatin Calcium | Generic | 283 | 112 | $4,273 |
| Valsartan | Generic | 270 | 93 | $9,930 |
| Amlodipine Besylate | Generic | 254 | 94 | $1,830 |
| Losartan Potassium | Generic | 189 | 68 | $2,960 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 175 | 79 | $2,281 |
| Entresto (Sacubitril/Valsartan) | Brand | 155 | 38 | $172,359 |
| Rosuvastatin Calcium | Generic | 155 | 68 | $3,341 |
| Eliquis (Apixaban) | Brand | 153 | 62 | $179,536 |
| Carvedilol | Generic | 150 | 57 | $1,781 |